US Patent Issued to BEYOND AIR on April 15 for "Nitric oxide inhalation therapy for infants with bronchiolitis" (Israeli, Canadian Inventors)

ALEXANDRIA, Va., June 5 -- United States Patent no. 12,274,830, issued on April 15, was assigned to BEYOND AIR LTD (Rehovot, Israel).

"Nitric oxide inhalation therapy for infants with bronchiolitis" was invented by Yossef Av-Gay (Vancouver, Canada), David Greenberg (Omer, Israel) and Asher Tal (Meytar, Israel).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides a method of delivering, by intermittent inhalation, 200 ppm to 320 ppm gNO for 10 to 45 minutes 2 to 5 times per day to provide a therapeutic amount of gaseous nitric oxide (gNO) wherein the therapeutic amount is a nitric oxide-load (NO load) of 300 ppm-hrs to 900 ppm-hrs of gNO per day over a period of at least 14 days to a patient i...